XML 41 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
Pro Forma Financial Information for Fiscal Years Ended December 31, 2011 and 2010 (UNAUDITED)
 12 Months Ended
Dec. 31, 2011
Pro Forma Financial Information for Fiscal Years Ended December 31, 2011 and 2010 (UNAUDITED) [Abstract]  
Pro Forma Financial Information for Fiscal Years Ended December 31, 2011 and 2010 (UNAUDITED)
20. Pro Forma Financial Information for Fiscal Years Ended December 31, 2011 and 2010 (UNAUDITED)

The following unaudited pro forma information gives effect to the acquisitions of ESI, Cell Cure Neurosciences, CTI assets and merger with Glycosan, as if the transactions took place on January 1, 2010.  The pro forma information does not necessarily reflect the results of operations that would have occurred had the entities been a single company during the periods presented.
 
 
 
Year Ended
December 31,
 
 
 
2011
 
 
2010
 
Revenues
 
$
4,406,075
 
 
$
4,840,333
 
 
 
 
 
 
 
 
 
 
(Loss) available to common shareholders
 
$
(16,560,381
)
 
$
(14,082,702
)
 
 
 
 
 
 
 
 
 
(Loss) per common share – basic
 
$
(0.35
)
 
$
(0.34
)
 
 
 
 
 
 
 
 
 
(Loss) per common share – diluted
 
$
(0.35
)
 
$
(0.34
)